Eslicarbazepine Acetate

CHEBI:CHEBI_747734

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
eslicarbazepine acetate
dosage_form
POWDER
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
route
ORAL
marketing_start_date
20131108
labeler_name
Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
product_ndc
51508-014
spl_id
1bae01a5-073f-0b76-e063-6394a90ad6a9
package_ndc
51508-014-01
brand_name
Aptiom
brand_name_base
Aptiom
application_number
NDA022416
rxcui
1491643
pharm_class
Cytochrome P450 2C19 Inhibitors [MoA]
active_ingredient_strength
50 kg/50kg
manufacturer_name
Camber Pharmaceuticals, Inc.
package_marketing_start_date
07-AUG-23
active_ingredient_name
ESLICARBAZEPINE ACETATE
package_description
25 kg in 1 CONTAINER (51508-014-01)
unii
BEA68ZVB2K
spl_set_id
3d0c9554-eaeb-4694-8089-00133fcadce3
upc
0331722428309
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class